Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cartilage Repair And Regeneration Market: By Types of Cartilage, By Treatment Modality By Treatment Type, By Application, By Surgical Procedure, By End User, and Geography
Cartilage Repair And Regeneration Market Size was valued at US$ 1,523.7 million in 2022 and is poised to grow at a CAGR of 12.8% over 2023-2029. The cartilage repair and regeneration market refers to the area of the medical industry that focuses on creating and offering remedies for the regeneration of damaged or degenerated cartilage in the human body, which is vital for supporting structural integrity and enabling pain-free joint movement. The increased prevalence of joint disorders such as osteoarthritis and rheumatoid arthritis drives the demand for effective cartilage repair and regeneration solutions market. According to WHO, in 2019, about 528 million people worldwide were living with osteoarthritis; 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Furthermore, the rise in the number of people suffering from sports-related injuries like athletes and active individuals, particularly those involving joints like the knees and shoulders is anticipated to propel the market in the upcoming years. According to a study conducted by Johns Hopkins Hospital, in the U.S. about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year with one-third of all injuries incurred in children.
Additionally, the development of non-invasive and regenerative techniques like ultrasound-guided therapies has provided several opportunities for the expansion of the market. Currently, 3D printing technology to aid in more efficient tissue regeneration and develop patient-specific scaffolds and structures that resemble the environment found in native cartilage is trending in the market. For instance, in 2021, Scientists from the Nakayama Lab at Saga University and Kyoto University in Japan have fabricated 3D-printed cartilage constructs from stem cells which could potentially be used to repair large cartilage defects in patients. But the regulatory hurdles for the approval of a particular product or therapy can be complex, time-consuming and expensive and may hinder the market growth. However, the increased incidence of osteoarthritis, increased funding and investments for research and launch of new products by key companies, increased government health initiatives, advanced infrastructure and instrumentation are anticipated to burgeon the market growth during the forecast years.
Study Period
2024-2030Base Year
2023CAGR
12.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The market is expected to rise as the number of knee replacement surgeries performed has increased and it dominates the market. The increase in the number of geriatric populations is anticipated to drive the market owing to the increase in damaged, worn, diseased knees or arthritis. According to the CDC, in the U.S., among adults aged 65 and older, 50% report ever having been diagnosed with arthritis. Similarly, according to NHS, more than 70,000 knee replacements are carried out in England and Wales each year, and the number is rising. Additionally, expanded R&D, the introduction of new products, mergers, and acquisitions are all contributing to the market's expansion. For instance, Minor League Baseball and Stryker worked together in April 2021 to officially designate Stryker as SmartRobotics' joint replacement partner. Stryker's newest innovation in joint replacement technology, Mako SmartRobotics, replaces the hip and knee using 3D CT-based planning software.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 1,523.7 million |
Market CAGR |
12.8% |
By Type |
|
By Treatment Modality |
|
By Treatment Type |
|
By Application |
|
By Surgical Procedure |
|
By End Users |
|
Download Free Sample Report
The cartilage repair and regeneration market size was valued at US$ 1,523.7 million in 2022 and is expected to grow at 12.8% CAGR over the forecast period 2023 – 2029.
Osiris Therapeutics, Inc. (U.S.), Smith + Nephew (U.K.), AlloSource (U.S.), Vericel Corporation (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), Stryker (U.S.), Anika Therapeutics, Inc. (U.S.), B. Braun SE (Germany), Orthocell Ltd. (Australia), Geistlich Pharma AG (Switzerland), Takeda Pharmaceutical Company Limited (Japan), CONMED Corporation (U.S.), The Future of Biotechnology, MEDIPOST (South Korea), BioTissue (U.S.), LifeNet Health (U.S.), RTI Surgical (U.S.) and Arthrex, Inc. (Germany) are a few companies operating in Cartilage Repair Market / Cartilage Regeneration market.
North America dominates the market with 13.8% CAGR in 2022, and is anticipated to grow with 14.1% CAGR over the forecast period 2023-2029.
1.Executive Summary |
2.Global Cartilage Repair And Regeneration Market Introduction |
2.1.Global Cartilage Repair And Regeneration Market - Taxonomy |
2.2.Global Cartilage Repair And Regeneration Market - Definitions |
2.2.1. By Type |
2.2.2. By Treatment Modality |
2.2.3. By Treatment Type |
2.2.4. By Application |
2.2.5. By Surgical Procedure |
2.2.6. By End User |
2.2.7. By Region |
3.Global Cartilage Repair And Regeneration Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Cartilage Repair And Regeneration Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Cartilage Repair And Regeneration Market By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Fibrocartilage |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Hyaline Cartilage |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Elastic Cartilage |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Cartilage Repair And Regeneration Market By Treatment Modality, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Cell-based |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Non-cell-based |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Cartilage Repair And Regeneration Market By Treatment Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Palliative |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Intrinsic Repair Stimulus |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Cartilage Repair And Regeneration Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Knee |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Spine |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Ankle |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Hip |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Others |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.Global Cartilage Repair And Regeneration Market By Surgical Procedure, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Chondroplasty and Microfracture |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Autologous Chondrocyte Implantation |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Osteochondral Autograft Transplantation |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Osteochondral Allograft Transplantation |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Juvenile Allograft Fragment |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Others |
9.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.6.3. Market Opportunity Analysis |
10.Global Cartilage Repair And Regeneration Market By End USer, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Ambulatory Care Centres |
10.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Hospitals and Clinics |
10.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Surgical Centres |
10.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Others |
10.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
11.Global Cartilage Repair And Regeneration Market By Region, 2018 - 2022 and Forecast 2023 - 20211 (Sales Value USD Million) |
11.1. North America |
11.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million) |
11.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.1.3. Market Opportunity Analysis |
11.2. Europe |
11.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million) |
11.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.2.3. Market Opportunity Analysis |
11.3. Asia Pacific (APAC) |
11.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million) |
11.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.3.3. Market Opportunity Analysis |
11.4. Middle East and Africa (MEA) |
11.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million) |
11.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.4.3. Market Opportunity Analysis |
11.5. Latin America |
11.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million) |
11.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.5.3. Market Opportunity Analysis |
12.North America Cartilage Repair And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Fibrocartilage |
12.1.2.Hyaline Cartilage |
12.1.3.Elastic Cartilage |
12.1.4.Others |
12.2. Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cell-based |
12.2.2.Non-cell-based |
12.3. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Palliative |
12.3.2.Intrinsic Repair Stimulus |
12.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Knee |
12.4.2.Spine |
12.4.3.Ankle |
12.4.4.Hip |
12.4.5.Others |
12.5. Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.Chondroplasty and Microfracture |
12.5.2.Autologous Chondrocyte Implantation |
12.5.3.Osteochondral Autograft Transplantation |
12.5.4.Osteochondral Allograft Transplantation |
12.5.5.Juvenile Allograft Fragment |
12.5.6.Others |
12.6. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.6.1.Ambulatory Care Centres |
12.6.2.Hospitals and Clinics |
12.6.3.Surgical Centres |
12.6.4.Others |
12.7. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.7.1.United States of America (USA) |
12.7.2.Canada |
13.Europe Cartilage Repair And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Fibrocartilage |
13.1.2.Hyaline Cartilage |
13.1.3.Elastic Cartilage |
13.1.4.Others |
13.2. Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Cell-based |
13.2.2.Non-cell-based |
13.3. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Palliative |
13.3.2.Intrinsic Repair Stimulus |
13.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Knee |
13.4.2.Spine |
13.4.3.Ankle |
13.4.4.Hip |
13.4.5.Others |
13.5. Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.Chondroplasty and Microfracture |
13.5.2.Autologous Chondrocyte Implantation |
13.5.3.Osteochondral Autograft Transplantation |
13.5.4.Osteochondral Allograft Transplantation |
13.5.5.Juvenile Allograft Fragment |
13.5.6.Others |
13.6. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.6.1.Ambulatory Care Centres |
13.6.2.Hospitals and Clinics |
13.6.3.Surgical Centres |
13.6.4.Others |
13.7. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.7.1.Germany |
13.7.2.France |
13.7.3.Italy |
13.7.4.United Kingdom (UK) |
13.7.5.Spain |
14.Asia Pacific (APAC) Cartilage Repair And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Fibrocartilage |
14.1.2.Hyaline Cartilage |
14.1.3.Elastic Cartilage |
14.1.4.Others |
14.2. Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Cell-based |
14.2.2.Non-cell-based |
14.3. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Palliative |
14.3.2.Intrinsic Repair Stimulus |
14.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Knee |
14.4.2.Spine |
14.4.3.Ankle |
14.4.4.Hip |
14.4.5.Others |
14.5. Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Chondroplasty and Microfracture |
14.5.2.Autologous Chondrocyte Implantation |
14.5.3.Osteochondral Autograft Transplantation |
14.5.4.Osteochondral Allograft Transplantation |
14.5.5.Juvenile Allograft Fragment |
14.5.6.Others |
14.6. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.6.1.Ambulatory Care Centres |
14.6.2.Hospitals and Clinics |
14.6.3.Surgical Centres |
14.6.4.Others |
14.7. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.7.1.China |
14.7.2.India |
14.7.3.Australia and New Zealand (ANZ) |
14.7.4.Japan |
14.7.5.Rest of APAC |
15.Middle East and Africa (MEA) Cartilage Repair And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
15.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.1.1.Fibrocartilage |
15.1.2.Hyaline Cartilage |
15.1.3.Elastic Cartilage |
15.1.4.Others |
15.2. Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.2.1.Cell-based |
15.2.2.Non-cell-based |
15.3. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.3.1.Palliative |
15.3.2.Intrinsic Repair Stimulus |
15.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.4.1.Knee |
15.4.2.Spine |
15.4.3.Ankle |
15.4.4.Hip |
15.4.5.Others |
15.5. Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.5.1.Chondroplasty and Microfracture |
15.5.2.Autologous Chondrocyte Implantation |
15.5.3.Osteochondral Autograft Transplantation |
15.5.4.Osteochondral Allograft Transplantation |
15.5.5.Juvenile Allograft Fragment |
15.5.6.Others |
15.6. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.6.1.Ambulatory Care Centres |
15.6.2.Hospitals and Clinics |
15.6.3.Surgical Centres |
15.6.4.Others |
15.7. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.7.1.GCC Countries |
15.7.2.South Africa |
15.7.3.Rest of MEA |
16.Latin America Cartilage Repair And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
16.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.1.1.Fibrocartilage |
16.1.2.Hyaline Cartilage |
16.1.3.Elastic Cartilage |
16.1.4.Others |
16.2. Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.2.1.Cell-based |
16.2.2.Non-cell-based |
16.3. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.3.1.Palliative |
16.3.2.Intrinsic Repair Stimulus |
16.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.4.1.Knee |
16.4.2.Spine |
16.4.3.Ankle |
16.4.4.Hip |
16.4.5.Others |
16.5. Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.5.1.Chondroplasty and Microfracture |
16.5.2.Autologous Chondrocyte Implantation |
16.5.3.Osteochondral Autograft Transplantation |
16.5.4.Osteochondral Allograft Transplantation |
16.5.5.Juvenile Allograft Fragment |
16.5.6.Others |
16.6. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.6.1.Ambulatory Care Centres |
16.6.2.Hospitals and Clinics |
16.6.3.Surgical Centres |
16.6.4.Others |
16.7. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
16.7.1.Brazil |
16.7.2.Mexico |
16.7.3.Rest of LA |
17. Competition Landscape |
17.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
17.2.1.AlloSource (U.S.) |
17.2.2.Anika Therapeutics, Inc. (U.S.) |
17.2.3.Arthrex, Inc. (Germany) |
17.2.4.Braun SE (Germany) |
17.2.5.BioTissue (U.S.) |
17.2.6.CONMED Corporation (U.S.) |
17.2.7.LifeNet Health (U.S.) |
17.2.8.MEDIPOST (South Korea) |
17.2.9.Medtronic (Ireland) |
17.2.10.Orthocell Ltd. (Australia) |
17.2.11.Osiris Therapeutics, Inc. (U.S.) |
17.2.12.RTI Surgical (U.S.) |
18. Research Methodology |
19. Appendix and Abbreviations |
Key Market Players